KATE DEVARNEY, PH.D.

Corporate Board Profile

Tech Score: 0/100

← Back to All Directors

TITAN PHARMACEUTICALS INC

Filing Date Source Excerpt
2020-11-02 /s/ Kate Devarney, Ph.D. Kate Devarney, PhD., President and Chief Operating Officer

Source material: SEC submissions metadata and DEF 14A proxy filings from EDGAR. Last updated: 2026-03-22